Replies to post #690928 on NorthWest Biotherapeutics Inc (NWBO)

[QL300]

“The company estimates that just over 450 people in England will be eligible to receive this new treatment.”

What happened to your 100 hard cap?

[Nemesis18]

Sounds like 100s per year to me. NiCE puts hard limits on max authorizations. What is your argument? This is the reason the UK is notorious for reimbusement and why the UK is a tiny revenue market. This is why you got to the US first if you are serious about making profit.

This is 100% correct. I think that the rationale behind the UK MAA filing was not one of massive income from this approval, rather to use that to leverage more debt off.
And hopefully get a buyout. Unfortunately, and MAA is non a biddable transferable asset in this regard .